HOUSTON / Feb 05, 2024 / Business Wire / U.S. Physical Therapy, Inc. (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced that it will report its financial results for the fourth quarter and year ended December 31, 2023 on Wednesday, February 28, 2024, after the stock market closes, with the conference call to follow the next morning, on Thursday, February 29, 2024.
Conference Call
Date: Thursday, February 29, 2024
Time: 10:30 am Eastern/9:30 am Central
Dial-In Number: (800) 267-6316 Primary or
(203) 518-9783 Alternate
Conference ID: USPHQ423
(In order to join this conference call, you will be required to provide the Conference ID listed above)
To participate, please call in 10 minutes prior to start time.
To listen to the live call, please go to www.usph.com and click on conference calls under the Investor Relations section. Please go to the website 15 minutes early to register, download and install any necessary audio software. If you are unable to listen live, a playback of the conference call can be accessed until May 29, 2024 at U.S. Physical Therapy’s website.
About U.S. Physical Therapy, Inc.
Founded in 1990, U.S. Physical Therapy, Inc. operates 671 outpatient physical therapy clinics in 42 states. The Company's clinics provide preventative and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, treatment for neurologically-related injuries and rehabilitation of injured workers. In addition to owning and operating clinics, the Company manages 43 physical therapy facilities for unaffiliated third parties, including hospitals and physician groups. The Company also has an industrial injury prevention services business which provides onsite services for clients’ employees including injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments.
More information about U.S. Physical Therapy, Inc. is available at www.usph.com The information included on that website is not incorporated into this press release.
Last Trade: | US$84.45 |
Daily Change: | 2.17 2.64 |
Daily Volume: | 55,954 |
Market Cap: | US$1.270B |
October 07, 2024 September 03, 2024 August 21, 2024 August 13, 2024 July 03, 2024 |
Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MOREAmneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB